HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents.

AuthorsMarcello Tucci, Elisa Roca, Laura Ferrari, Anna Pia, Alberto Dalla Volta, Francesca Bedussi, Consuelo Buttigliero, Giorgio Vittorio Scagliotti, Sandra Sigala, Alfredo Berruti
JournalEndocrine (Endocrine) Vol. 64 Issue 3 Pg. 724-726 (06 2019) ISSN: 1559-0100 [Electronic] United States
PMID31065911 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Androstenes
  • Antibodies, Antinuclear
  • Hypoglycemic Agents
  • abiraterone
  • Prednisone
Topics
  • Aged
  • Androstenes (adverse effects, therapeutic use)
  • Antibodies, Antinuclear (adverse effects, therapeutic use)
  • Diabetes Mellitus, Type 2 (complications, drug therapy)
  • Drug Therapy, Combination (adverse effects)
  • Humans
  • Hypoglycemia (chemically induced)
  • Hypoglycemic Agents (therapeutic use)
  • Male
  • Prednisone (adverse effects, therapeutic use)
  • Prostatic Neoplasms (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: